Pharma Aids (DHA:PHARMAID) Enterprise Value : BDT1,418.5 Mil (As of May. 16, 2025)

Pharma Aids Enterprise Value Chart

Pharma Aids Annual Data
	Trend	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23	Jun24
Enterprise Value		Get a 7-Day Free Trial					1,264.28	1,221.78	2,518.88	2,463.34	2,071.16

Pharma Aids Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Enterprise Value	Get a 7-Day Free Trial															1,935.86	2,071.16	2,050.78	1,789.77	1,670.02

Competitive Comparison of Pharma Aids's Enterprise Value

For the Medical Instruments & Supplies subindustry, Pharma Aids's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Aids's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pharma Aids's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Pharma Aids's Enterprise Value falls into.

Pharma Aids Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Pharma Aids's Enterprise Value for the fiscal year that ended in Jun. 2024 is calculated as

Pharma Aids's Enterprise Value for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Aids  (DHA:PHARMAID) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Pharma Aids's EV-to-EBIT for today is

Pharma Aids's current Enterprise Value is BDT1,418.5 Mil.
Pharma Aids's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT75.6 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Pharma Aids's EV-to-EBITDA for today is:

Pharma Aids's current Enterprise Value is BDT1,418.5 Mil.
Pharma Aids's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT82.1 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Pharma Aids's EV-to-Revenue for today is:

Pharma Aids's current Enterprise Value is BDT1,418.5 Mil.
Pharma Aids's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT416.8 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Pharma Aids's EV-to-FCF for today is:

Pharma Aids's current Enterprise Value is BDT1,418.5 Mil.
Pharma Aids's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-16.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Aids Enterprise Value Related Terms

Thank you for viewing the detailed overview of Pharma Aids's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Aids Business Description